Advancing Botanical Drug Development Act of 2026

Key Points

• This bill gives companies that create new plant-based medicines 12 years of protection from competition. During this time, the government cannot approve cheaper generic versions of the drug.
• Botanical drugs are made from plants and often have many active ingredients that work together. Because plants vary in nature, these drugs are much harder and more expensive to test than regular pills.
• Supporters say this change is needed because current laws do not give companies enough time to earn back the money they spend on research. They hope this will lead to new treatments for long-term illnesses.
• If this becomes law, it could mean more natural medicine options at the pharmacy in the future. However, it might also keep prices higher for a longer time because generic versions would be delayed.

Impact Analysis

Govbase has not yet run an impact analysis on this legislation.